Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma

Radiotherapy and Oncology

Volumn 103, Issue 3, 2012, Pages 367-372

  Biswas, Tithi ^a   Culakova, Eva ^b   Friedberg, Jonathan W ^c   Kelly, Jennifer L ^c   Dhakal, Sughosh ^c   Liesveld, Jane ^c   Phillips, Gordon L ^c   Constine, Louis S ^c  

^a EAST CAROLINA UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Autologous stem cell transplant; High dose chemotherapy; Hodgkin lymphoma; Involved field radiation therapy

Indexed keywords

ARABINOSIDE; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOSINE; DEXAMETHASONE; ETOPOSIDE; IFOSFAMIDE; METHYLPREDNISOLONE;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HODGKIN DISEASE; HUMANS; MALE; RECURRENCE; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84861805244     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.12.031     Document Type: Article

References (23)

1. A.J. Swerdlow Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma Eur J Nucl Med Mol Imaging 30 2003 S3 S12
2. C. Herbst, and A. Engert Metaanalysis of early stage Hodgkin's lymphoma Acta Haematol 125 2011 32 38
3. A. Engert, V. Diehl, and J. Franklin Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's Lymphoma: 10 years of follow-up of the GHSG HD9 study J Clin Oncol 27 2009 4548 4554
4. A. Moskowitz, M.A. Perales, and T. Kewalramani Outcomes for patients who fail high dose chemo-radiotherapy and autologous stem cell rescue relapsed and primary refractory Hodgkin's lymphoma Br J Haematol 146 2009 158 163
5. D.C. Linch, D. Winfield, and A.H. Goldstone Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial Lancet 341 1993 1051 1054
6. N. Schmitz, B. Pfistner, and M. Sextro Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial Lancet 359 2002 2065 2071
7. H.M. Lazarus, P.A. Rowlings, and M.J. Zhang Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry J Clin Oncol 17 1999 534
8. G.L. Phillips, S.N. Wolff, and R.H. Herzig Treatment of progressive hodgkin's disease with intensive chemoradiotherapy and autologous stem cell transplantation Blood 73 1989 2086 2092
9. R.M. Meyer, M.K. Gospodarowicz, and J.M. Connors Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited stage Hodgkin's lymphoma: National Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group J Clin Oncol 23 2005 4634 4642
10. V. Diehl, C. Brillant, and A. Engert HD10: investigating reduction of combined modality treatment intensity in early stage Hodgkin's lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG) J Clin Oncol 23 2005 561s [abstract 6506]
11. J.C. Poen, R.T. Hoppe, and S.J. Horning High dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival Int J Radiat Oncol Biol Phys 36 1996 3 12
12. J.E. Lancet, A.P. Rapoport, and R. Brasacchio Autotransplantation for relapsed or refractory Hodgkin's disease: long term follow up and analysis of prognostic factors Bone Marrow Transplant 22 1998 265 271
13. M.M. Wendland, J.D. Asch, M.A. Pulsipher, J.W. Thomson, D.C. Shrieve, and D.K. Gaffney The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoetic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin's disease Am J Clin Oncol 29 2006 189 195
14. S.T. Kahn, C.R. Flowers, M.J. Lechowicz, K. Hollenbach, and P.A. Johnstone Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: optimizing involved field radiotherapy in transplant patients Cancer J 11 2005 425 431
15. A.J. Mundt, G. Sibley, S. Williams, D. Hallahan, J. Nautiyal, and R.R. Weichselbaum Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease Int J Radiat Oncol Biol Phys 33 1995 261 270
16. R.D. Pezner, A. Nademanee, J.C. Niland, N. Vora, and S.J. Forman Involved field radiation therapy for Hodgkin's disease autologous born marrow transplantation regimens Radiother Oncol 34 1995 23 29
17. U. Popat, C. Hosing, and R.M. Saliba Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma Bone Marrow Transplant 33 2004 1015 1023
18. D.E. Reece, J.M. Connors, and J.J. Spinelli Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy Blood 83 1994 1193 1199
19. M. Andre, M. Henry-Amar, and J.L. Pico Comparison of high dose therapy and autologous stem cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case control study. Societe Francaise de Greffe de Moelle J Clin Oncol 17 1999 222 229
20. K.S. Baker, B.G. Gordon, and T.G. Gross Autologous hematopoietic stem cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents J Clin Oncol 17 1999 825 831
21. A. Krishnan, S. Bhatia, and M.L. Slovak Predictors of therapy related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors Blood 95 2000 1588 1593
22. R.W. Tsang, M.K. Gospodarowicz, S.B. Sutcliffe, M. Crump, and A. Keating Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease Eur J Cancer 35 1999 73 78
23. K.A. Goodman, E. Riedel, V. Serrano, S. Gulati, C.H. Moskowitz, and J. Yahalom Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma J Clin Oncol 32 2008 5240 5247